Repeat testing with an intact FGF-23 assay demonstrated elevation (92 pg/mL), supporting a diagnosis of TIO despite the remote FCM exposure and negative NetSpot scan (Etwok Inc., Dover, DE, United States) for tumor localization. Here, FGF23 is linked to neoplasm.